Hu M[au] - Search Results

Year	Number of Results
1948	1
1955	1
1958	1
1962	1
1963	1
1964	1
1965	1
1973	2
1974	1
1975	1
1977	2
1978	3
1979	4
1980	3
1981	3
1982	5
1983	7
1984	4
1985	4
1986	6
1987	13
1988	13
1989	14
1990	12
1991	15
1992	19
1993	25
1994	24
1995	26
1996	30
1997	34
1998	29
1999	53
2000	42
2001	48
2002	61
2003	80
2004	111
2005	128
2006	131
2007	136
2008	183
2009	176
2010	240
2011	298
2012	399
2013	406
2014	497
2015	532
2016	604
2017	639
2018	754
2019	811
2020	1025
2021	569

1

Paradoxical Mitophagy Regulation by PINK1 and TUFm.

Lin J, Chen K, Chen W, Yao Y, Ni S, Ye M, Zhuang G, Hu M, Gao J, Gao C, Liu Y, Yang M, Zhang Z, Zhang X, Huang J, Chen F, Sun L, Zhang X, Yu S, Chen Y, Jiang Y, Wang S, Yang X, Liu K, Zhou HM, Ji Z, Deng H, Haque ME, Li J, Mi LZ, Li Y, Yang Y. Lin J, et al. Among authors: hu m. Mol Cell. 2020 Nov 19;80(4):607-620.e12. doi: 10.1016/j.molcel.2020.10.007. Epub 2020 Oct 27. Mol Cell. 2020. PMID: 33113344

2

A multicenter RCT of noninvasive ventilation in pneumonia-induced early mild acute respiratory distress syndrome.

He H, Sun B, Liang L, Li Y, Wang H, Wei L, Li G, Guo S, Duan J, Li Y, Zhou Y, Chen Y, Li H, Yang J, Xu X, Song L, Chen J, Bao Y, Chen F, Wang P, Ji L, Zhang Y, Ding Y, Chen L, Wang Y, Yang L, Yang T, Weng H, Li H, Wang D, Tong J, Sun Y, Li R, Jin F, Li C, He B, Sun L, Wang C, Hu M, Yang X, Luo Q, Zhang J, Tan H, Wang C; ENIVA Study Group. He H, et al. Among authors: hu m. Crit Care. 2019 Sep 4;23(1):300. doi: 10.1186/s13054-019-2575-6. Crit Care. 2019. PMID: 31484582 Free PMC article. Clinical Trial.

3

Berberine in the treatment of ulcerative colitis: A possible pathway through Tuft cells.

Xiong X, Cheng Z, Wu F, Hu M, Liu Z, Dong R, Chen G. Xiong X, et al. Among authors: hu m. Biomed Pharmacother. 2021 Feb;134:111129. doi: 10.1016/j.biopha.2020.111129. Epub 2020 Dec 24. Biomed Pharmacother. 2021. PMID: 33348308 Free article. Review.

4

Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.

Subbiah V, Shen T, Terzyan SS, Liu X, Hu X, Patel KP, Hu M, Cabanillas M, Behrang A, Meric-Bernstam F, Vo PTT, Mooers BHM, Wu J. Subbiah V, et al. Among authors: hu m. Ann Oncol. 2021 Feb;32(2):261-268. doi: 10.1016/j.annonc.2020.10.599. Epub 2020 Nov 5. Ann Oncol. 2021. PMID: 33161056 Free PMC article.

5

IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophages.

Wang X, Lin L, Lan B, Wang Y, Du L, Chen X, Li Q, Liu K, Hu M, Xue Y, Roberts AI, Shao C, Melino G, Shi Y, Wang Y. Wang X, et al. Among authors: hu m. Sci Adv. 2020 Nov 25;6(48):eabb7389. doi: 10.1126/sciadv.abb7389. Print 2020 Nov. Sci Adv. 2020. PMID: 33239287 Free PMC article.

6

GluD2- and Cbln1-mediated competitive interactions shape the dendritic arbors of cerebellar Purkinje cells.

Takeo YH, Shuster SA, Jiang L, Hu MC, Luginbuhl DJ, Rülicke T, Contreras X, Hippenmeyer S, Wagner MJ, Ganguli S, Luo L. Takeo YH, et al. Among authors: hu mc. Neuron. 2021 Feb 17;109(4):629-644.e8. doi: 10.1016/j.neuron.2020.11.028. Epub 2020 Dec 21. Neuron. 2021. PMID: 33352118

7

Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study.

Hu M, Zhou Q, Zheng R, Li X, Ling J, Chen Y, Jia J, Xie C. Hu M, et al. BMC Pulm Med. 2020 Dec 24;20(1):324. doi: 10.1186/s12890-020-01354-w. BMC Pulm Med. 2020. PMID: 33357219 Free PMC article.

8

Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes.

Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y, Kumar T, Hu M, Sei E, Davis A, Wang F, Shaitelman SF, Wang JR, Chen K, Moulder S, Lai SY, Navin NE. Gao R, et al. Among authors: hu m. Nat Biotechnol. 2021 May;39(5):599-608. doi: 10.1038/s41587-020-00795-2. Epub 2021 Jan 18. Nat Biotechnol. 2021. PMID: 33462507

9

Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation.

Kubo N, Ishii H, Xiong X, Bianco S, Meitinger F, Hu R, Hocker JD, Conte M, Gorkin D, Yu M, Li B, Dixon JR, Hu M, Nicodemi M, Zhao H, Ren B. Kubo N, et al. Among authors: hu m. Nat Struct Mol Biol. 2021 Feb;28(2):152-161. doi: 10.1038/s41594-020-00539-5. Epub 2021 Jan 4. Nat Struct Mol Biol. 2021. PMID: 33398174

10

Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies.

Hegde A, Andreev-Drakhlin AY, Roszik J, Huang L, Liu S, Hess K, Cabanillas M, Hu MI, Busaidy NL, Sherman SI, Dadu R, Grubbs EG, Ali SM, Lee J, Elamin YY, Simon GR, Blumenschein GR Jr, Papadimitrakopoulou VA, Hong D, Meric-Bernstam F, Heymach J, Subbiah V. Hegde A, et al. Among authors: hu mi. ESMO Open. 2020 Oct;5(5):e000799. doi: 10.1136/esmoopen-2020-000799. ESMO Open. 2020. PMID: 33097651 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results